Basel Medical Group Ltd (BMGL)

NASDAQ: BMGL · Real-Time Price · USD

3.280

+0.260 (8.61%)

At close: Oct 2, 2026, 4:00 PM EDT

3.140

-0.140 (-4.27%)

After-hours: Oct 2, 2026, 7:54 PM EDT

Basel Medical Group Income Statement

Financials in millions SGD. Fiscal year is July - June.

Millions SGD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Operating Revenue	14.55	11.32	10.05	9.7	10.66
Other Revenue	0.18	0.04	-	0.05	-
Revenue	14.74	11.35	10.05	9.75	10.66
Revenue Growth	47.34%	12.97%	3.12%	-8.55%	-
Cost of Revenue	12.67	8.95	5.89	5.58	2.72
Gross Profit	2.06	2.4	4.16	4.16	7.94
Selling, General & Admin	0.03	0.14	0	1.05	5.78
Other Operating Expenses	3.49	3.22	1.44	0.55	-0.31
Operating Expenses	6.4	4.55	1.97	2.16	5.48
Operating Income	-4.34	-2.14	2.2	2	2.46
Interest Expense	-0.32	-0.2	-0.18	-0.24	-0.32
Interest & Investment Income	0.03	0.08	-	0.3	0.25
Other Non Operating Income (Expenses)	2.63	1.56	0.39	0.07	-
EBT Excluding Unusual Items	-1.99	-0.7	2.4	2.13	2.39
Impairment of Goodwill	-10.35	-10.35	-	-	-
Pretax Income	-10.4	-11.05	2.4	2.13	2.39
Income Tax Expense	-0.24	-0.42	0.33	0.35	0.41
Earnings From Continuing Operations	-10.16	-10.64	2.07	1.78	1.98
Minority Interest in Earnings	0.11	0	-	-	-
Net Income	-10.05	-10.64	2.07	1.78	1.98
Net Income to Common	-10.05	-10.64	2.07	1.78	1.98
Net Income Growth	-	-	16.23%	-9.84%	-
Shares Outstanding (Basic)	2	2	1	1	1
Shares Outstanding (Diluted)	2	2	1	1	1
Shares Change	23.41%	15.60%	-	-	-
EPS (Basic)	-6.01	-6.79	1.53	1.32	1.46
EPS (Diluted)	-6.01	-6.79	1.53	1.32	1.46
EPS Growth	-	-	16.23%	-9.84%	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Free Cash Flow	-12.9	-14.94	2.5	2.59	2.7
Free Cash Flow Per Share	-7.72	-9.54	1.85	1.92	2.00
Gross Margin	14.01%	21.18%	41.43%	42.71%	74.48%
Operating Margin	-29.43%	-18.85%	21.84%	20.55%	23.09%
Profit Margin	-68.19%	-93.67%	20.62%	18.30%	18.56%
Free Cash Flow Margin	-87.52%	-131.58%	24.89%	26.61%	25.37%
EBITDA	-4.06	-2.03	2.23	2.03	2.48
EBITDA Margin	-27.53%	-17.91%	22.14%	20.86%	23.30%
D&A For EBITDA	0.28	0.11	0.03	0.03	0.02
EBIT	-4.34	-2.14	2.2	2	2.46
EBIT Margin	-29.43%	-18.85%	21.84%	20.55%	23.09%
Effective Tax Rate	-	-	13.80%	16.34%	17.12%

SEC Filings: 10-K · 10-Q